Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 80Head and Neck Neoplasms 72Nasopharyngeal Carcinoma 61Prostatic Neoplasms 51Oropharyngeal Neoplasms 30Carcinoma, Non-Small-Cell Lung 27Rectal Neoplasms 23Carcinoma, Squamous Cell 23Breast Neoplasms 23Glioblastoma 22Uterine Cervical Neoplasms 18Carcinoma 18Neoplasm Metastasis 16Brain Neoplasms 16Nasopharyngeal Neoplasms 15Pancreatic Neoplasms 14Lung Neoplasms 13Gliosarcoma 13Glioma 13Esophageal Neoplasms 13Radiation Injuries 12Mouth Neoplasms 12Laryngeal Neoplasms 12Esophageal Squamous Cell Carcinoma 12Astrocytoma 12Tongue Neoplasms 11Hypopharyngeal Neoplasms 11Sarcoma 10Neoplasms 10Salivary Gland Neoplasms 8

Interventions

tremelimumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Immunoglobulin G 1Disulfides 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Malignant Female Reproductive System Neoplasm × Radiotherapy, Intensity-Modulated × Clear all
NCT04516135 2026-02-25

Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
28 enrolled

Metastatic Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡